What is Sagimet Biosciences Inc (SGMT)?
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for metabolic and cardiovascular diseases. The company’s research primarily targets conditions such as obesity, non-alcoholic steatohepatitis (NASH), and related cardiometabolic disorders. Sagimet Biosciences utilizes a platform approach to identify and develop small molecule therapeutics aimed at modulating key biological pathways involved in metabolic regulation. The company engages in both in-house research and strategic collaborations to advance its pipeline candidates through various stages of clinical development. Its scientific efforts are supported by a team with expertise in drug discovery, clinical development, and regulatory affairs. Sagimet Biosciences operates within the broader biotechnology industry, contributing to the advancement of treatments addressing significant unmet medical needs in metabolic health. The company’s activities encompass preclinical studies, clinical trials, and regulatory interactions necessary for the progression of its therapeutic candidates toward potential market approval.
Sagimet Biosciences Inc Stock Price Today: Live Overview
The price today is shaped by active market participation, with Franklin Street Properties Corp trading at $4.66. Its price has moved within the range of $4.51 to $4.84, changing by -1.7354% today.
FAQ: Sagimet Biosciences Inc (SGMT)
What is the current price of SGMT stock?
The stock is currently priced at $4.66.
Does SGMT pay dividends?
Sagimet Biosciences Inc does not pay dividends.
Does SGMT have a formal corporate presence or regional headquarters in the UAE?
The company does not maintain an official presence or subsidiary in the UAE and operates primarily through partnerships.
What is SGMT best known for?
Sagimet Biosciences Inc is most famous for developing therapies targeting metabolic diseases.
What assets are typically shown together with SGMT?
Commonly shown alongside SGMT: KUD, Uxin Ltd, Univest Financial Corp
Latest shares articles



